Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Tumor-associated macrophage
Email alerts
Tumor-associated macrophage
A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment
Yu-Tzu
Liu
,
Tai-Chung
Tseng
,
Ruey-Shyang
Soong
,
Chun-Yi
Peng
,
Yu-Hsing
Cheng
,
Shiu-Feng
Huang
,
Tsung-Hsien
Chuang
,
Jia-Horng
Kao
,
Li-Rung
Huang
Journal for ImmunoTherapy of Cancer
Dec 2018,
6
(1)
144;
DOI:
10.1186/s40425-018-0462-3
Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors
Edward
Hammond
,
Nicole M.
Haynes
,
Carleen
Cullinane
,
Todd V.
Brennan
,
Darryn
Bampton
,
Paul
Handley
,
Tomislav
Karoli
,
Fleur
Lanksheer
,
Liwen
Lin
,
Yiping
Yang
,
Keith
Dredge
Journal for ImmunoTherapy of Cancer
Dec 2018,
6
(1)
54;
DOI:
10.1186/s40425-018-0363-5
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Michael A.
Cannarile
,
Martin
Weisser
,
Wolfgang
Jacob
,
Anna-Maria
Jegg
,
Carola H.
Ries
,
Dominik
Rüttinger
Journal for ImmunoTherapy of Cancer
Dec 2017,
5
(1)
53;
DOI:
10.1186/s40425-017-0257-y
Special collections
COVID-19
(37)
Editor's choice
JITC
Basic Tumor Immunology
(382)
Case Reports
(178)
Clinical Trials Monitor
(16)
Clinical/Translational Cancer Immunotherapy
(697)
Commentary/Editorials
(114)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(36)
Guidelines and Consensus Statements
(24)
Imaging and Immunotherapy
Immune Cell Therapies and Immune Cell Engineering
(113)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(281)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(90)
Reviews
(189)
Open access
(2327)
Press releases
